NCT01715428View on ClinicalTrials.gov

Liraglutide and Cardio-Metabolic Risk Markers

CompletedOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Type-2 Diabetes
Trial Locations (1)

90127

University Hospital of Palermo, Palermo

All Listed Sponsors
lead

University of Palermo

OTHER

NCT01715428 - Liraglutide and Cardio-Metabolic Risk Markers | Biotech Hunter | Biotech Hunter